This paper describes the technology and early clinical development of the CAR T NKR-2 platform and elucidates its fundamental differences with classical CAR-T…

immunotherapy

EuroBiotech Report: AstraZeneca rejection, Novartis phase 3 fail, $30M round, BioLineRx and Pierre Fabre

Cidara fails phase 2 study, drops med in vulvovaginal candidiasis

Chutes & Ladders: J&J vet Bridget Ross jumps ship to Henry Schein